Skip to content

Alloplastic Graft vs Xenograft for Horizontal Alveolar Ridge Augmentation

Clinical and Radiological Evaluation Using Bone Graft Materials in Augmentation of Alveolar Bone Deficiency in Bilateral Posterior Mandible: A Randomized Controlled Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07608744
Enrollment
20
Registered
2026-05-27
Start date
2019-10-01
Completion date
2020-10-01
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Loss, Edentulous Jaw

Keywords

atrophic mandible, bone augmentation, Decompression technique, alveolar ridge augmentation

Brief summary

This prospective split-mouth randomized controlled trial compared horizontal alveolar ridge augmentation using alloplastic bone graft versus xenograft, both performed simultaneously with implant placement using the decompression technique in the posterior mandible. Outcomes included postoperative edema, pain, soft tissue healing, and horizontal bone gain at 6 months assessed by CBCT.

Interventions

DEVICEAlloplastic bone graft

Alloplastic bone graft with collagen membrane, simultaneous implant placement with decompression technique

DEVICEXenograft

Xenograft with collagen membrane, simultaneous implant placement with decompression technique

Sponsors

Ege University
Lead SponsorOTHER
Bonegraft Biyolojik Malzemeler San. ve Tic. A.S.
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Bilateral mandibular posterior edentulism with indication for implant-supported rehabilitation * Sufficient vertical bone height but insufficient horizontal bone width for implant placement * No infection at surgical site * Non-smoker * No head-and-neck radiotherapy within 2 years * No uncontrolled systemic disease (controlled systemic conditions with INR \<1.2 acceptable) * Signed informed consent

Exclusion criteria

* No indication for implant-supported prosthesis * Smoker * Active infection at surgical site * Head-and-neck radiotherapy within 2 years * Uncontrolled systemic disease * Allergy to study materials * Pregnancy * Age under 18 * Medications interfering with surgical procedures * History of mandibular fracture * Contraindication to surgery determined by consultation * Psychiatric disorder or inability to communication

Design outcomes

Primary

MeasureTime frameDescription
Horizontal Alveolar Bone Gain6 monthsChange in horizontal alveolar bone width measured by CBCT at baseline and 6 months

Secondary

MeasureTime frameDescription
Postoperative Edema7 daysFacial edema assessed by measuring three surface distances (lateral orbital rim to mandibular angle, tragus to oral commissure, tragus to pogonion) at baseline, day 2, and day 7
Postoperative Pain7 daysPostoperative pain assessed using the Visual Analogue Scale (VAS); score range 0-10; higher scores indicate worse pain. VAS scores recorded daily for 7 days
Soft Tissue Healing7 daysWound healing assessed using the Landry wound healing index; score range 1-5; higher scores indicate better healing. Landry wound healing index assessed at postoperative days 2 and 7

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026